Arkema OTC Stock Today

ARKAY
 Stock
  

USD 93.37  5.06  5.73%   

Market Performance
0 of 100
Odds Of Distress
Less than 38
Arkema ADR is trading at 93.37 as of the 7th of July 2022; that is 5.73 percent up since the beginning of the trading day. The stock's open price was 88.31. Arkema ADR has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Arkema ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of July 2020 and ending today, the 7th of July 2022. Click here to learn more.
Fiscal Year End
December
Category
Basic Materials
ISIN
US0412321095
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. The company has 73.96 M outstanding shares. More on Arkema ADR

Moving together with Arkema ADR

0.73JPMJP Morgan Chase Earnings Call  This WeekPairCorr
0.77HPQHP Inc Potential GrowthPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Arkema ADR OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Arkema ADR's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arkema ADR or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Arkema ADR generated a negative expected return over the last 90 days
ChairmanThierry Henaff
Average Analyst Recommendation
Analysts covering Arkema ADR report their recommendations after researching Arkema ADR's financial statements, talking to executives and customers, or listening in on Arkema ADR's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Arkema ADR. The Arkema consensus assessment is calculated by taking the average forecast from all of the analysts covering Arkema ADR.
Strong Buy1 Opinion
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Arkema ADR's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Arkema ADR [ARKAY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arkema ADR's market, we take the total number of its shares issued and multiply it by Arkema ADR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Arkema ADR classifies itself under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 73.96 M outstanding shares. Arkema ADR has accumulated about 2.28 B in cash with 915 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 30.9.
Check Arkema ADR Probability Of Bankruptcy
Ownership
Arkema ADR retains a total of 73.96 Million outstanding shares. Almost 100.0 percent of Arkema ADR outstanding shares are held by regular investors with 0.0 (percent) owned by insiders and only 0.12 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Arkema Ownership Details

Arkema Stock Price Odds Analysis

What are Arkema ADR's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Arkema ADR jumping above the current price in 90 days from now is over 95.75%. The Arkema ADR probability density function shows the probability of Arkema ADR otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Arkema ADR has a beta of 0.8324. This suggests as returns on the market go up, Arkema ADR average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arkema ADR will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Arkema ADR is significantly underperforming DOW.
  Odds Below 93.37HorizonTargetOdds Above 93.37
4.21%90 days
 93.37 
95.75%
Based on a normal probability distribution, the odds of Arkema ADR to move above the current price in 90 days from now is over 95.75 (This Arkema ADR probability density function shows the probability of Arkema OTC Stock to fall within a particular range of prices over 90 days) .

Arkema ADR Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Arkema ADR market risk premium is the additional return an investor will receive from holding Arkema ADR long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arkema ADR. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Arkema ADR's alpha and beta are two of the key measurements used to evaluate Arkema ADR's performance over the market, the standard measures of volatility play an important role as well.

Arkema Stock Against Markets

Picking the right benchmark for Arkema ADR otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arkema ADR otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arkema ADR is critical whether you are bullish or bearish towards Arkema ADR at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Arkema ADR without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Module

Arkema ADR Corporate Directors

Arkema ADR corporate directors refer to members of an Arkema ADR board of directors. The board of directors generally takes responsibility for the Arkema ADR's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arkema ADR's board members must vote for the resolution. The Arkema ADR board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Patrice Breant - Director - Shareholder Employees RepresentativeProfile
Victoire Margerie - Independent DirectorProfile
Marc Pandraud - Independent DirectorProfile
Helene MoreauLeroy - Non-Executive Independent DirectorProfile

Investing Arkema ADR

You need to understand the risk of investing before taking a position in Arkema ADR. The danger of trading Arkema ADR is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arkema ADR is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arkema ADR. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arkema ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Arkema ADR information on this page should be used as a complementary analysis to other Arkema ADR's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Arkema OTC Stock analysis

When running Arkema ADR price analysis, check to measure Arkema ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema ADR is operating at the current time. Most of Arkema ADR's value examination focuses on studying past and present price action to predict the probability of Arkema ADR's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arkema ADR's price. Additionally, you may evaluate how the addition of Arkema ADR to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Arkema ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arkema ADR. If investors know Arkema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arkema ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.75
Market Capitalization
6.5 B
Quarterly Revenue Growth YOY
0.3
Return On Assets
0.0691
Return On Equity
0.25
The market value of Arkema ADR is measured differently than its book value, which is the value of Arkema that is recorded on the company's balance sheet. Investors also form their own opinion of Arkema ADR's value that differs from its market value or its book value, called intrinsic value, which is Arkema ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arkema ADR's market value can be influenced by many factors that don't directly affect Arkema ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arkema ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine Arkema ADR value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arkema ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.